The Disruptors: Driving I&I Therapy Adoption with Oral Formulations

Focus on Inflammation and Immunology has grown massively over the past couple of decades. Initial focus was on the utilization of antibodies to block key inflammatory cytokines. Beyond cytokines, the focus shifted to also include B-cell and complement targets. More recently, the field has evolved to incorporate novel chemistry to provide patients with simple, oral solutions in a world dominated by biologics.

The Disruptors: Driving I&I Therapy Adoption with Oral Formulations

Grand Ballroom